Oxidative Stress in Multiple Exercise-Regulated Bone Homeostasis
Oxidative stress mediates exercise to regulate bone homeostasis. A) Low concentrations of ROS act as signaling molecules to maintain bone homeostasis and the balance between osteoblasts and osteoclasts, promote stress resistance processes, such as the induction of the antioxidant defense system, reduce the incidence of stress-related diseases and delay the aging process. High concentrations of ROS play an important role in the pathological changes during the progression of OP. Excessive ROS production can enhance the responsiveness of osteoclast precursors to RANKL, stimulating M-CSF and RANKL expression and increasing the RANKL/OPG ratio. Activation of the differentiation of osteoclast precursor cells increases the number and activity of osteoclasts and enhances the activity of bone resorption. An increase in ROS production inhibits the expression of the Wnt/β-catenin signaling pathway but activates the expression of PPARγ and supports adipogenesis at the expense of osteoblastic genesis. Inhibiting the differentiation of osteoblasts and inducing the apoptosis of osteoblasts and osteocytes inhibits bone formation. B) Moderate regular exercise can improve the body's antioxidant defense ability and inhibit excessive ROS. Exercise has a prevention and treatment effect on OP caused by many factors, including age-associated OP, postmenopausal OP, and type 2 diabetes-associated OP. In addition, among bone health problems caused by some special factors, such as fluorosis and SOD2 deficiency, exercise has also been confirmed to play a good therapeutic role and protect bone from oxidative stress damage. C) Exercise-induced muscle factors regulate the link between oxidative stress and bone homeostasis. Irisin and BAIBA are secreted by skeletal muscle during exercise. Irisin upregulates SIRT3 expression, reduces excessive oxidative stress and improves mitochondrial autophagy in ASCs thereby improving the osteogenic differentiation activity of ASCs.BAIBA signals through MRGPRD, to inhibit mitochondrial breakdown in osteocytes, thereby protecting osteocytes from ROS-induced apoptosis.